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Abstract – Although microscopic examination of stool samples remains the reference method for the diagnosis of
intestinal protozoal infections, these techniques are time-consuming and require operators who are experienced and
well trained. Molecular biology seems to offer performances at least equivalent in terms of sensitivity and specificity
for certain parasites. This study aimed to compare three multiplex PCR assays on 93 prospectively collected positive
stools (prospective cohort) and a panel of 12 more Cryptosporidium-positive samples (Cryptosporidium panel).
On the prospective cohort, the sensitivity was 89%, 64% and 41% for Giardia sp. detection for BD MaxTM,
G-DiaParaTM and RIDAGENE, respectively and 75%, 100% and 100% for C. parvum/hominis detection. The sen-
sitivity of the RIDAGENE assay for all Cryptosporidium species was 100%, and for D. fragilis 71%. All the tech-
niques obtained the same results for E. histolytica detection, with one positive sample. All species in the
Cryptosporidium panel were identified by the RIDAGENE PCR. The BD MaxTM and G-DiaParaTM assays detected
only C. parvum/hominis with the exception of one positive sample for C. meleagridis. No assay showed satisfactory
results for all parasites simultaneously, and the DNA extraction seems to be the critical step. More studies are needed
to standardize this procedure.
Key words: multiplex PCR, intestinal protozoa, Giardia intestinalis, Entamoeba histolytica, Cryptosporidium sp.,
Dientamoeba fragilis.
Résumé – Comparaison de trois kits commerciaux de PCR multiplex pour la mise en évidence de protozoaires
intestinaux. Bien que l’examen microscopique des selles reste la méthode de référence pour le diagnostic des
protozooses intestinales, ces techniques sont chronophages et demandent une grande expérience et des opérateurs
entrainés. La biologie moléculaire semble offrir des performances au moins équivalentes en termes de sensibilité
comme de spécificité pour certains parasites. Cette étude visait à comparer trois techniques de PCR multiplex sur
une cohorte de 93 selles positives collectées prospectivement et un panel de 12 échantillons positifs à
Cryptosporidium. Respectivement pour BD MaxTM, G-DiaParaTM et RIDAGENE la sensibilité était de 89 %,
64 % et 41 % pour la détection de Giardia sp. et 75 %, 100 % et 100 % pour la détection de C. parvum/hominis.
La sensibilité de la technique RIDAGENE pour l’ensemble des espèces de Cryptosporidium était de 100 % et de
71 % pour D. fragilis. Toutes les techniques ont obtenu les mêmes résultats pour la détection d’E. histolytica
(1 échantillon positif). Toutes les espèces de Cryptosporidium ont été détectées par la PCR RIDAGENE. Les
techniques BD MaxTM et G-DiaParaTM ont détecté seulement C. parvum/hominis en dehors d’un échantillon positif
à C. meleagridis. Aucun essai n’a montré de résultats satisfaisants pour l’ensemble des parasites simultanément et
l’extraction d’ADN semble être l’étape critique. Plus d’études sont nécessaires afin de standardiser cette procédure.
Introduction
Because the world is in the era of globalization, laborato-
ries are confronted with a growing number of parasitic diseases
affecting people living in endemic areas, migrants, travellers
and international workers [19]. Intestinal protozoan parasites
are responsible for a broad spectrum of clinical manifestations,
ranging from mild gastrointestinal symptoms to life-threaten-
ing watery or haemorrhagic diarrhoea, and can even lead to
complications with extra-intestinal localizations. Among them,
giardiasis and dientamoebiasis are a major cause of disease in
terms of frequency [1, 22], and cryptosporidiosis and amoebi-
asis are, respectively, the third and fourth parasitic causes of
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death worldwide [8]. However, these infections are often
neglected and underreported.
Diagnosis of protozoan intestinal infections mainly relies
on microscopic examination after stool concentration, which
remains the reference method, as it enables detection of all
parasites. However, it is time-consuming and requires special
skills and well-trained operators, since protozoan parasites
are somewhat difficult to identify, particularly when they are
present in low numbers. Therefore, new diagnostic methods
are needed. While the development of molecular techniques
marked a turning point in the diagnosis of bacterial and viral
diseases, these techniques are more difficult to apply to the
diagnosis of intestinal protozoosis, due to the thick wall of
parasite (oo)cysts, making DNA extraction difficult, and due
to the high density of PCR inhibitors in stool samples. Many
procedures have been developed, often based on pre-treatment
of stool samples by mechanical, chemical or thermic lysis, and
followed by various extraction systems, like silica-column-
based or magnetic extraction, with variable performances.
Today, molecular biology techniques could help to save time,
provided that they are able to detect in a same run most
protozoan parasites infecting humans, and that they can be
automated.
In this study, we evaluated three commercial multiplex PCR
assays, BD MaxTM Enteric Parasite Panel (Becton Dickinson,
Pont-de-Claix, France), G-DiaParaTM (Diagenode Diagnostics,
Liege, Belgium), and RIDAGENE Parasitic Stool Panel I
(R-BioPharm, Darmstadt, Germany), and compared them to
microscopy, using the same panel of stool samples found posi-
tive for protozoa by microscopic examination. The BD MaxTM
assay is fully automated, and the two other methods were
evaluated after automated extraction using MagNA Pure 96
(Roche Diagnostics, Meylan, France), with the aim of adapting
amplification steps on a flow system (Roche).
Materials and methods
Stool samples
This study included 90 stool samples analysed prospec-
tively at the Consultation Unit of the Laboratory of Parasitology
of the University Hospital of Rennes (France) over an 18-month
period (October 2015–July 2017) and tested positive for Giar-
dia intestinalis, Cryptosporidium sp., Entamoeba histolytica/
dispar and/or Dientamoeba fragilis by microscopic examina-
tion (Fig. 1), so-called ‘‘prospective cohort’’. Three additional
samples positive for commensal protozoa and/or helminths
were also included in order to assess the specificity of the
assays. These 93 samples were analysed by experienced opera-
tors, as quickly as permitted by the opening hours of the labo-
ratory and the timeframe for transport of the stool. The
procedure consisted in a microscopic examination of a fresh
stool wet mount and in-house concentration methods (Bailen-
ger’s, Thebault’s and merthiolate-iodine-formalin biphasic
methods [5]). Cryptosporidium detection relied on Henriksen’s
modified Ziehl-Neelsen staining on concentration pellets. An
aliquot of stool sample was also frozen at 80 C until DNA
extraction. When Cryptosporidium sp. oocysts were detected,
a stool sample was sent to the French National Reference
Centre for Cryptosporidiosis (NRCC) (University Hospital of
Rouen, France) for species identification by sequencing analy-
sis. For all samples, parasites were semi-quantified as ‘‘rare’’,
‘‘few’’, ‘‘quite numerous’’, ‘‘numerous’’ and ‘‘many’’. Twelve
samples provided by the NRCC were also included to extend
our cohort with stool samples positive for various species of
Cryptosporidium (‘‘Cryptosporidium panel’’). These specimens
were stored frozen with potassium dichromate 2.5%. The final
stool panel consisted of 44 G. intestinalis, 23 Cryptosporidium
spp. (13 C. parvum, 5 C. felis, 3 C. hominis, 1 C. canis, and
1 C. meleagridis), 13 E. histolytica/dispar, and 28 D. fragilis.
Six samples were poly-parasitized: 2 with D. fragilis and
G. intestinalis, 2 with E. histolytica/dispar and G. intestinalis,
and 2 with Cryptosporidium sp. and G. intestinalis.
DNA extraction using MagNA Pure 96
Stool DNA was extracted with BD MaxTM (Becton
Dickinson, Franklin Lakes, NJ, USA) and MagNA Pure 96
(Roche Diagnostics, Meylan, France). For each sample, a small
amount (approximately pea-sized) of thawed stool was
suspended in 500 lL of PBS and vortexed, except for liquid
stools, which were used plain. In case of insufficient quantity
of stool, the volume of PBS was reduced proportionally.
Suspensions were centrifuged for 5 s at 500 g, and 90 lL of
supernatant were added to 90 lL of MagNA Pure 96 Bacteria
Lysis Buffer (Roche Diagnostics) and 20 lL of proteinase K
(Roche Diagnostics). After homogenization, the mix was
incubated for 10 min at 65 C, followed by 10 min at 95 C.
Then, two cycles of freezing and thawing were performed (at
least 10 min at 80 C followed by 10 min at 95 C). Each
incubation step was followed by vortexing to homogenize the
suspension. After a short centrifugation (few seconds at max
speed), 20 lL and 10 lL of the RIDAGENE Parasitic Stool
Panel I (PSP I) (R-BioPharm) and DiaControlDNATM Cy5
(Diagenode Diagnostics) internal controls, respectively, were
added. Mixes were then extracted with a MagNA Pure 96
system (Roche Diagnostics Ltd) using MagNA Pure 96 DNA
and Viral NA Small Volume (Roche Diagnostics Ltd), and
eluted in a 100 lL volume. Other pre-treatment procedures
were tested on 17 samples: one with a bead-beating step before
thermal and chemical lysis, and another with only chemical
lysis. Bead-beating was done with MagNA Lyser Green Beads
(Roche Diagnostics) using the MagNA Lyser device (Roche
Diagnostics Ltd), for 35 sec at maximum speed and repeated
twice, followed by centrifugation for 1 min at 8000 g, before
lysing the supernatant as described above. DNA extracts were
stored at 80 C until amplification with the RIDAGENE
PSP I and the G-DiaParaTM assays.
Amplification
DNA extracts were amplified by the RIDAGENE PSP
I (R-BioPharm) and G-DiaParaTM (Diagenode Diagnostics)
assays using a LightCycler 480 II device (Roche Diagnostics),
following the manufacturer’s recommendations. As D. fragilis
can be detected only by RIDAGENE PSP I, a total of 65
and 93 samples were analysed with the G-DiaParaTM and the
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RIDAGENE PSP I assays, respectively. The pathogens possi-
bly detected by each assay are shown in Figure 1. Briefly, for
the RIDAGENE PSP I assay, 5 lL of DNA were added to
19.9 lL of mix and 0.1 lL of Taq polymerase solution, and
amplified for 45 cycles with a 15 s extension step at 60 C.
For the G-DiaParaTM assay, 5 lL of DNA were added to
20 lL of mix composed of 5 lL of Master Mix 5X (Diagen-
ode Diagnostics), 2.5 lL of probes and primers for parasite
detection, 2.5 lL of probes and primers for internal control
detection, and 10 lL of water suitable for molecular biology.
Amplification was carried out for 45 cycles with an extension
step at 60 C for 60 s. Positive and negative controls were
included in each run on the LC 480 II (provided by PCR kits).
False-negative results with the RIDAGENE PSPI and G-Dia-
ParaTM assays were re-analysed using DNA extracts diluted at
1:10. For two stool specimens (1 C. parvum and 1 C. melea-
gridis), the remaining quantity was insufficient for extraction
on MagNA Pure 96, thus PCR assays were performed using
BD MaxTM extracts stored at 80 C.
Extraction and amplification with the BD MaxTM
system
A small quantity of thawed stool was collected with a
10 lL-calibrated loop and suspended in a tube containing
1.5 mL of lysis buffer, supplied in the BD MaxTM EPP kit.
Tubes were heated for 52 min in a pre-warmed heater device,
before being transferred into a BD MaxTM system rack con-
taining unitized dried reagents. Processing by the BD MaxTM
system includes a DNA extraction step with magnetic beads
and multiplex amplification using Taqman technology. Each
rack allows the analysis of up to 24 samples in a same run. Pos-
itive controls (positive clinical samples) were included in the
Figure 1. Study flow chart. 1EPP: Enteric Parasite Panel; 2PSP: Parasitic Stool Panel.
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first run only. As with the G-DiaParaTM assay, 65 samples were
analysed with this technique (exclusion of stools positive for
D. fragilis only). After analysis, all remaining extracts were
stored at 80 C.
Statistics
Microscopy was considered as the reference method to
calculate the sensitivity and specificity of each PCR assay.
Results
Impact of the pre-treatment method on PCR
performance
As shown in Table 1, the bead-beating pre-treatment
inhibited the detection of Cryptosporidium spp. in the selected
samples. The detection of G. intestinalis was moderately
affected, while E. histolytica and D. fragilis detection was
apparently not affected, with the limitation of the small number
of samples. Freezing and thawing cycles were maintained
because of better amplification of internal controls (CT from
25–29 versus 30–33 without, data not shown), even if the
number of positive stools was not impacted.
Evaluation of the 3 PCR assays’ performances
The detection of Giardia by the BD MaxTM, G-DiaParaTM
and RIDAGENE assays yielded respectively a sensitivity of
89%, 64% and 41%, respectively (Table 2). False-negative
results were obtained with samples showing ‘‘rare’’ or ‘‘few’’
parasites by microscopy, except for 4 which were negative by
G-DiaParaTM and/or RIDAGENE PSP I assays while quanti-
fied as ‘‘quite numerous’’ or ‘‘numerous’’ by microscopy. Five
false-negative samples were obtained with the BD MaxTM; in
none of them the results of the internal control suggested the
presence of PCR inhibitors. All three assays detected a positive
stool which was negative by microscopy, leading to a specificity
of 95%–98%. As illustrated in Figure 2, samples tested positive
with the RIDAGENE PSP I assay were also positive with the
G-DiaParaTM and BD MaxTM assays, and almost all samples
positive with the G-DiaParaTM assay were also positive with
the BD MaxTM assay.
The sensitivity for Cryptosporidium sp. detection by BD
MaxTM, G-DiaParaTM and RIDAGENE PSP I assays was
for the prospective cohort 55%, 73% and 100%, respectively.
When considering only samples positive for C. parvum and
C. hominis, as targeted by their respective primers, the first
two assays reached sensitivities of 75% and 100%, respectively.
In this prospective cohort, the RIDAGENE assay detected all
positive stools, the G-DiaParaTM assay detected all C. parvum/
hominis, and the BD MaxTM assay did not detect two stools
positive for C. parvum/hominis because of PCR inhibitors
(Table 2). Specificity was excellent for all techniques (100%).
When considering the 12 samples from the NRCC
Cryptosporidium panel (Table 3), the RIDAGENE assay
missed two Cryptosporidium sp. (one C. hominis sample
containing PCR inhibitors and one C. felis), the BD MaxTM
assay missed two C. hominis positive stools, and G-DiaParaTM
detected all C. parvum/hominis. None of the G-DiaParaTM and
BD MaxTM assays detected the other species except C. melea-
gridis. For three of the four false-negative results by the BD
MaxTM assay, the internal control highlighted PCR inhibitors.
The RIDAGENE assay detected at least one sample for each
Cryptosporidium species tested, confirming the wide detection
of Cryptosporidium species.
Because microscopy cannot be used to identify
E. histolytica/dispar species, neither sensitivity nor specificity
could be calculated. However, results were identical for the
three assays, which detected one sample positive for
E. histolytica among the stools positive for E. histolytica/dispar.
Another sample was collected from the same patient 4 days
before this one (not included): microscopic examination
showed only commensal protozoa (Entamoeba coli and
Blastocystis hominis) but all PCR assays were positive for
E. histolytica.
Among the 28 stools positive for D. fragilis, 20 tested
positive with the RIDAGENE assay, yielding a sensitivity
of 71%. Among the eight false-negative samples observed,
all were quantified as ‘‘rare’’ or ‘‘few’’, except one quantified
‘‘quite numerous’’ by microscopy. No PCR inhibitor was
detected by internal controls. Two samples negative by micro-
scopy were positive by the RIDAGENE assay (specificity
97%), one contained Endolimax nanus, Chilomastix mesnili
and Pentatrichomonas intestinalis, and the other contained
Blastocystis hominis, G. intestinalis and C. mesnili.
PCR inhibitors were detected in 26% of stools by the
BD MaxTM assay (17/65), impacting only detection of
Cryptosporidium sp., and 0% (0/65) and 1% (1/93) for the
G-DiaParaTM and RIDAGENE assays, respectively. The
extract with inhibitors detected by the RIDAGENE assay
was associated with a false-negative result for Giardia sp.
The amplification of diluted extracts did not enable recovery
of false-negative results.
Discussion
The aim of this study was to evaluate and compare three
PCR assays for the detection of intestinal protozoa. Perfor-
mances obtained on our prospective cohort of 93 consecutive
frozen stool samples from 93 patients, positive by microscopic
examination, were heterogeneous among assays and targets.
Overall, we observed high specificity, but variable sensitivities
for Giardia intestinalis and Cryptosporidium sp. detection. BD
MaxTM was the most sensitive for G. intestinalis detection
(89%), followed by G-DiaparaTM (64%) and RIDAGENE
(41%). These two latter sensitivities are poorer than previously
Table 1. Results for tested pre-treatments.
Results by RIDAGENE assay (n/N)
Without bead-beating With bead-beating
G. intestinalis 5/8 3/8
Cryptosporidium sp. 4/5 0/5
E. histolytica 1/1 1/1
D. fragilis 2/3 2/3
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observed in other studies. Indeed, Laude et al. observed 92%
sensitivity with the G-DiaParaTM assay on a smaller series of
38 Giardia-positive stool samples after extraction with the
QiaSymphony device (Qiagen, Courtaboeuf, France) [12]. To
our knowledge, there are no evaluations of the performances
of the RIDAGENE Parasitic Stool Panel I in the literature,
but similar panels from the same manufacturer showed sensitiv-
ities of 95%–100% in some reports [13, 15, 21]. Nevertheless,
in these reports, only few data are available about the micro-
scopic examination performed: it is therefore difficult to inter-
pret the observed performances. It is well known that the
extraction process influences the results of amplification. These
disappointing results cannot therefore be solely attributed to the
PCR assay. As discussed further, even though we tried to opti-
mize DNA extraction from cysts by using various pre-treatment
protocols, many factors involved in this step could interfere in
our study. However, it can be stated that the G-DiaParaTM assay
performed better than the RIDAGENE assay for Giardia
detection, using our extraction technique. The BD MaxTM
system yielded results in agreement with the 93.5%–100%
sensitivity observed in the literature [14, 17, 18]. Interestingly,
one sample was negative by microscopy and positive with the
three assays. This patient was previously diagnosed with
G. intestinalis, so this result could either reflect the presence
of specific DNA without living parasite, or parasite recrudes-
cence, or resistance to treatment. This highlights that, while
molecular techniques are adapted for the diagnosis of intestinal
protozoosis, more studies are needed to define their role in post-
treatment follow-up.
Regarding Cryptosporidium detection, the G-DiaParaTM
and RIDAGENE assays showed very good sensitivity and
specificity using routine specimens. The BD MaxTM assay
had a slightly lower sensitivity mainly impacted by PCR inhi-
bitors, leading to 25% (2/8 C. parvum/hominis) false-negative
results. Despite this, the BD MaxTM assay was the only to
detect C. parvum DNA in a stool negative by microscopy
(sample not included in the panel, but tested retrospectively).
The patient had been previously diagnosed with cryptosporid-
iosis and this negative stool was sampled before the onset of
antiparasitic treatment, thus this could rather be a ‘‘true
positive’’ undetected by microscopy. A possible explanation
for this apparently variable performance might be that the
BD MaxTM system performs better than the MagNA Pure 96
system for nucleic extraction, although it is more susceptible
to PCR inhibitors. Interestingly, the BD MaxTM and G-DiaPar-
aTM assays detected C. meleagridis DNA, whereas they are
designed to detect only C. parvum/hominis, which could be
explained by the fact that these species are genetically close.
Such cross-detection is not systematic, as in the study of Laude
et al. a stool positive for C. meleagridis was undetected by the
G-DiaParaTM assay [12]. Finally, even though C. parvum/
C. hominis are the species mainly responsible for cryptosporid-
iosis worldwide, the use of PCR assays restricted to these
Table 2. Performances of the multiplex PCR assays compared to microscopy on 93 positive samples analysed routinely na: not applicable;
nd: not determined.
Sensitivity n/N (%) Specificity n/N (%)
BD MaxTM G-DiaParaTM RIDAGENE BD MaxTM G-DiaParaTM RIDAGENE
G. intestinalis 39/44 (89%) 28/44 (64%) 18/44 (41%) 20/21 (95%) 20/21 (95%) 48/49 (98%)
Cryptosporidium sp. 6/11 (55%) 8/11 (73%) 11/11 (100%) 54/54 (100%) 54/54 (100%) 82/82 (100%)
C. parvum/hominis 6/8 (75%) 8/8 (100%) 8/8 (100%) na na na
D. fragilis na na 20/28 (71%) na na 63/65 (97%)
E. histolytica/dispar nd1 nd1 nd1 nd1 nd1 nd1
1 As microscopy does not enable species identification, sensitivity and specificity could not be determined for E. histolytica detection.
However, concordant positive results were obtained with the 3 PCR assays for 1 sample.
Figure 2. Venn diagram of results for Giardia detection. All
Giardia-positive samples detected by the RIDAGENE assay were
detected by the G-DiaParaTM and the BD MaxTM assays, and almost
all those detected by the G-DiaParaTM assay were detected by the
BD MaxTM assay (1 exception).
Table 3. Results for the Cryptosporidium sp. panel from the French
NRCC
Sensitivity: n/N
BD MaxTM G-DiaParaTM
RIDA
GENE
Cryptosporidium sp. (N = 12) 7/12 9/12 10/12
C. parvum (N = 5) 5/5 5/5 5/5
C. hominis (N = 3) 1/3 3/3 2/3
C. felis (N = 2) 0/2 0/2 1/2
C. canis (N = 1) 0/1 0/1 1/1
C. meleagridis (N = 1) 1/1 1/1 1/1
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species should be followed by microscopic examination of
stools, if the PCR result is negative. In fact, in France, species
other than C. parvum/C. hominis account for about 10% of
cases [4], which would remain undiagnosed by these assays.
Detection of E. histolytica was entirely concordant among
the three assays. Results were coherent in that the positive
sample came from a patient who was positive for E. histolytica/
dispar by microscopy. This patient had another stool positive by
PCR for E. histolytica, but negative by microscopic examina-
tion, suggesting that microscopy missed one positive sample.
Today, molecular biology is critical in the diagnosis of
E. histolytica and allows us to distinguish real cases of
amoebiasis from carriage of E. dispar, E. moshkovskii or
E. bangladeshi, which are poorly detected using antigenic
assays [3, 20, 23, 24]. This discrimination is crucial to rational-
ize drug consumption and to avoid misdiagnosis.
The detection of D. fragilis by the RIDAGENE assay
showed a sensitivity of 71%, and was mainly affected by low
parasitic loads. Diagnosis of dientamoebiasis by microscopy
is highly difficult, principally because trophozoites are pleo-
morphic and degrade rapidly outside the intestinal lumen.
Therefore, PCR is considered to be the reference method for
D. fragilis detection [22]. However, available molecular assays
are at risk of false positivity because of cross-reactions [6].
In our cohort, two samples were positive whereas microscopic
examination of the stool sample was negative and these
patients had no previous history of dientamoebiasis. These
samples contained Pentatrichomonas hominis and Chilomastix
mesnili, two flagellated protozoa, which are likely to induce
cross-reactions. Although the stool containing P. hominis was
unique in this cohort, other stools contained C. mesnili, some-
times in high quantity, and did not yield false-positive results
by the RIDAGENE assay. This suggests that P. hominis could
be responsible for cross-reactions, which is concordant with
the fact that, unlike C. mesnili, it belongs to the Trichomonada,
together with D. fragilis. Nevertheless, the only way to confirm
this hypothesis would be to sequence PCR products obtained
with the RIDAGENE assay primers targeting D. fragilis.
As the pathogenicity of D. fragilis remains debated [22, 25],
the need to include this protozoa in multiplex PCR panels
may be questionable. However, even though the relationship
between D. fragilis carriage and diarrhoea is unclear, reports
of gastrointestinal symptoms related to heavy parasitic loads
are frequent [22]. Furthermore, many studies on D. fragilis
pathogenicity relied on microscopic examination of stools,
which is not an ideal method as discussed above, and could
impact the strength of the observed association between
parasite carriage and symptoms. For these reasons, molecular
biology could add value for further epidemiological studies
on the pathogenicity of this protozoon.
The most striking observation in this study is the heteroge-
neous sensitivity, especially for G. intestinalis detection.
The employed DNA extraction process could be insufficient in
this respect, explaining the lower performances of the
G-DiaParaTM and RIDAGENE assays. For example, Adamska
et al. compared various methods for extraction of DNA from
G. intestinalis cysts and concluded that each stage before
amplification was crucial [2]. They also reported their best
results with an overnight proteinase K treatment instead of short
incubations. While some studies reported better DNA extraction
of G. intestinalis after a bead-beating step of stools, many others
observed similar results without mechanical lysis [7, 10, 12, 24].
Interestingly, some authors also reported poorer DNA extrac-
tion after this step, depending of the extraction technique used
and on the type of beads. For example, in the study of Kaisar
et al. [11], mechanical lysis diminished the number of positive
samples for G. intestinalis and D. fragilis. In the same way, a
multicentric study showed highly variable effects of the bead-
beating step on the extraction of Cryptosporidium DNA, espe-
cially with the MagNA Lyser Green Beads which impacted it
negatively [16]. The other major factor is the extraction device
itself. In the literature, few studies employed the MagNA Pure
96 for protozoa detection. The most interesting one is that of
Gotfred-Rasmussen et al., describing sensitivity of 91% for
Giardia detection by an in-house PCR, compared to direct
fluorescent assay. [9] No pre-treatment was applied, except
incubation in a transport medium. The extraction reagent
was the DNA and Viral NA Large Volume, which enables treat-
ment of higher sample input than the Small Volume reagent we
used.
Finally, sensitivity could also be affected by PCR inhibitors.
Internal control DNA is supposed to detect them, but using the
recommended volumes, the Ct of amplification was always low,
thus unlikely to be able to detect moderate inhibition. However,
a dilution to 1:10 of DNA extracts from false-negative samples
did not allow us to recover the positivity of any sample, which
seems to rule out the hypothesis that PCR inhibitors would be
the source of false-negative results. Another hypothesis could
be that long storage at 80 C (up to one year before extrac-
tion) could have altered DNA and impact performances.
However, the BD MaxTM assay detected most Giardia sp. pos-
itive stools, showing that DNA quality was unlikely an issue.
Basically, no assay showed a sufficiently outstanding perfor-
mance for the detection of all parasites in routine use to discard
microscopic examination of stools. Although multiplex PCR
techniques would be of great interest in diagnostic labs with
automated platforms, more studies are needed to standardize
procedures for DNA extraction, which is the critical step.
Furthermore, the pathogens targeted by these assays are the
most common and most pathogenic protozoa and fit with
90% of screened patients in routine diagnosis, but the sole
use of these assays could lead to the non-diagnosis of other
protozoa such as Cystoisospora belli, Cyclospora cayetanensis,
and Blastocystis hominis. Moreover, no marketed multiplex
PCR assay targets helminths, which rules out the possibility
of abandoning microscopy. Nevertheless, a reliable molecular
assay for protozoa detection would lighten microscopic exami-
nation of stools, as helminths are easily detected. In this context,
particularly for laboratories with a strong migrant clientele,
single tests with enlarged parasitic panels would be welcome.
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